Hospital Pharmacy - May 2017 - 337
337
Hager et al.
Table 2. Critical Care Pharmacy Residency Program Directors Survey Results: Market Perception.
n (%)a
Over the past 5 years, CC positions at your organization have:
Increased
Remained stable
Decreased
How easy would it be for you or a peer to find alternative CC employment?
Very easy (<1 month)
Easy (1-3 months)
Difficult (3-6 months)
Very difficult (>6 months)
What is your perception of the CC pharmacist market in your area?
High demand: difficult to fill open positions
Moderate demand: some difficulty filling open positions
Demand is in balance with supply
Demand is less than the available supply
Demand is much less than the available supply
In the past 5 years, how many CC pharmacists have left the organization
(primary responsibility >50% in ICU setting)?
Mean ± SD
NA
20 (30.8)
44 (67.7)
1 (1.5)
NA
2 (3.2)
29 (46.0)
23 (36.5)
9 (14.3)
NA
1 (1.6)
18 (29.0)
17 (27.4)
20 (32.3)
6 (9.7)
2.0 ± 1.9
Note. CC = critical care; ICU = intensive care unit.
a
Percentages are for individual question responses not of total survey respondents.
Table 3. Initial Positions Following Critical Care PGY2 Training by Year.a
Internal position in critical care
External position in critical care
Internal position non-critical care
External position non-critical care
Fellowship/PGY3
Nonpharmacy position
NA; did not have a resident
Total
2014-2015
2013-2014
2012-2013
2011-2012
2010-2011
Total
20 (29.9%)
35 (52.2%)
8 (11.9%)
3 (4.5%)
0 (0.0%)
1 (1.5%)
0 (0.0%)
67
14 (20.9%)
40 (59.7%)
9 (13.4%)
3 (4.5%)
0 (0.0%)
0 (0.0%)
1 (1.5%)
67
19 (30.2%)
34 (54.0%)
4 (6.3%)
4 (6.3%)
1 (1.6%)
0 (0.0%)
1 (1.6%)
63
16 (27.6%)
29 (50.0%)
3 (5.2%)
5 (8.6%)
1 (1.7%)
0 (0.0%)
4 (6.9%)
58
19 (38.8%)
22 (44.9%)
2 (4.1%)
4 (8.2%)
0 (0.0%)
0 (0.0%)
2 (4.1%)
49
88
160
26
19
2
1
8
304
Note. PGY2 = postgraduate year 2; NA = not applicable; PGY3 = postgraduate year 3.
a
Percentages are for individual question responses not of total survey respondents.
peers would have a moderately easy time finding new
employment in critical care, with a job search taking between
1 and 6 months.
When asked about their perception of the current job market and how they would advise students who were interested
in pursuing a PGY2, CC RPDs indicated that ambulatory
care, emergency medicine, and hematology/oncology had
the best job prospects for PGY2 training over the next 5
years, while psychiatry had the worst (Table 4).
Directors of Pharmacy Survey
From October 6, 2015, to November 2, 2015, 82 respondents
completed the DOP survey. The average bed size of participating organizations was 410 beds (range, 25-2153). The
average number of full-time equivalent (FTE) inpatient
pharmacists was 39, with an average of 3.9 FTEs responsible
for critical care.
Critical care pharmacist turnover. Turnover of critical care
pharmacists was quite low according to the DOP survey,
with an average of 0.95 pharmacists leaving an organization over the past 5 years. In contrast to the RPD group, the
DOP group indicated that they expected an increase in critical care trained pharmacist positions, with the average
expected growth over the next 5 years being 1.25 FTEs.
When asked to describe their critical care pharmacist hiring
practices over the past 5 years, the DOP group overwhelmingly supported hiring PGY2 CC trained pharmacists for
these positions; an average of 1.4 PGY2 CC pharmacists
were hired over the past 5 years, with 1.3 of these being
PGY2 CC trained (Table 5).
Table of Contents for the Digital Edition of Hospital Pharmacy - May 2017
Editorial, For Sale: FDA Priority Review Vouchers
Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Pharmacists’ Knowledge of the Cost of Laboratory Testing
Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 317
Hospital Pharmacy - May 2017 - 318
Hospital Pharmacy - May 2017 - 319
Hospital Pharmacy - May 2017 - 320
Hospital Pharmacy - May 2017 - 321
Hospital Pharmacy - May 2017 - 322
Hospital Pharmacy - May 2017 - 323
Hospital Pharmacy - May 2017 - Editorial, For Sale: FDA Priority Review Vouchers
Hospital Pharmacy - May 2017 - 325
Hospital Pharmacy - May 2017 - Current FDA-Related Drug Information; Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals
Hospital Pharmacy - May 2017 - Summaries of Safety Labeling Changes Approved by the FDA: Boxed Warnings
Hospital Pharmacy - May 2017 - 328
Hospital Pharmacy - May 2017 - 329
Hospital Pharmacy - May 2017 - ISMP Adverse Drug Reactions: Levofloxacin-Induced Neuroexcitation and Hallucinations Statin-Induced Muscle Rupture Mefloquine-Induced Rhabdomyolysis Methimazole-Induced
Hospital Pharmacy - May 2017 - 331
Hospital Pharmacy - May 2017 - 332
Hospital Pharmacy - May 2017 - 333
Hospital Pharmacy - May 2017 - Critical Care Pharmacist Market Perceptions: Comparison of Critical Care Program Directors and Directors of Pharmacy
Hospital Pharmacy - May 2017 - 335
Hospital Pharmacy - May 2017 - 336
Hospital Pharmacy - May 2017 - 337
Hospital Pharmacy - May 2017 - 338
Hospital Pharmacy - May 2017 - 339
Hospital Pharmacy - May 2017 - 340
Hospital Pharmacy - May 2017 - Capecitabine, Oxaliplatin, and Bevacizumab (BCapOx) Regimen for Metastatic Colorectal Cancer
Hospital Pharmacy - May 2017 - 342
Hospital Pharmacy - May 2017 - 343
Hospital Pharmacy - May 2017 - 344
Hospital Pharmacy - May 2017 - 345
Hospital Pharmacy - May 2017 - 346
Hospital Pharmacy - May 2017 - 347
Hospital Pharmacy - May 2017 - Clinical Pharmacy Discharge Counseling Service and the Impact on Readmission Rates in High-Risk Patients
Hospital Pharmacy - May 2017 - 349
Hospital Pharmacy - May 2017 - 350
Hospital Pharmacy - May 2017 - 351
Hospital Pharmacy - May 2017 - 352
Hospital Pharmacy - May 2017 - Mannitol Prescribing Practices With Cisplatin Before and After an Educational Newsletter Intervention
Hospital Pharmacy - May 2017 - 354
Hospital Pharmacy - May 2017 - 355
Hospital Pharmacy - May 2017 - 356
Hospital Pharmacy - May 2017 - Pharmacists’ Knowledge of the Cost of Laboratory Testing
Hospital Pharmacy - May 2017 - 358
Hospital Pharmacy - May 2017 - 359
Hospital Pharmacy - May 2017 - 360
Hospital Pharmacy - May 2017 - Adverse Drug Reaction Reporting Practices Among United Arab Emirates Pharmacists and Prescribers
Hospital Pharmacy - May 2017 - 362
Hospital Pharmacy - May 2017 - 363
Hospital Pharmacy - May 2017 - 364
Hospital Pharmacy - May 2017 - 365
Hospital Pharmacy - May 2017 - 366
Hospital Pharmacy - May 2017 - Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital
Hospital Pharmacy - May 2017 - 368
Hospital Pharmacy - May 2017 - 369
Hospital Pharmacy - May 2017 - 370
Hospital Pharmacy - May 2017 - 371
Hospital Pharmacy - May 2017 - 372
Hospital Pharmacy - May 2017 - 373
Hospital Pharmacy - May 2017 - Formulary Drug Reviews
Hospital Pharmacy - May 2017 - 375
Hospital Pharmacy - May 2017 - 376
Hospital Pharmacy - May 2017 - 377
Hospital Pharmacy - May 2017 - 378
Hospital Pharmacy - May 2017 - 379
Hospital Pharmacy - May 2017 - 380
Hospital Pharmacy - May 2017 - 381
Hospital Pharmacy - May 2017 - 382
Hospital Pharmacy - May 2017 - 383
Hospital Pharmacy - May 2017 - 384
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com